- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,812USD£2,088GBP
- Report
- May 2025
- 267 Pages
Global
From €4431EUR$4,950USD£3,804GBP
- Report
- December 2023
- 265 Pages
Global
From €4431EUR$4,950USD£3,804GBP
- Report
- November 2024
- 498 Pages
Global
From €4431EUR$4,950USD£3,804GBP
- Report
- January 2023
- 131 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- December 2021
- 296 Pages
Global
From €2350EUR$2,625USD£2,018GBP
€4700EUR$5,250USD£4,035GBP
- Report
- March 2025
Global
From €4387EUR$4,900USD£3,766GBP
- Report
- November 2024
- 120 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- August 2025
- 120 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- November 2022
- 54 Pages
Global
- Report
- August 2025
- 180 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 181 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 187 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 199 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 196 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 191 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- August 2025
- 196 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- June 2025
- 182 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- July 2024
- 182 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- November 2024
- 338 Pages
Global
From €4476EUR$5,000USD£3,843GBP

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule.
The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules.
Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more